All In MedTech

FDA Clearance Tracker · P960009-S333

Activa Deep Brain Stimulation Therapy System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 3, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 3, 2019

Approved

Time to decision

222 days

Received Nov 23, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P960009-S333
Device name
Activa Deep Brain Stimulation Therapy System
Applicant location
Minneapolis, MN
Received
Nov 23, 2018
Decided
Jul 3, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P960009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

Approval for the Model A620 Activa DBS Patient Programmer Application.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.